Product correctly added to cart.

discount label
Saroglitazar
View 3D

Biosynth logo

Saroglitazar

CAS: 495399-09-2

Ref. 3D-VUA39909

50mg
1,954.00 €
100mg
3,258.00 €
250mg
5,594.00 €
Estimated delivery in United States, on Thursday 6 Feb 2025

Product Information

Name:
Saroglitazar
Description:

Saroglitazar is a drug that belongs to the class of peroxisome proliferator-activated receptor (PPAR) agonists. It has been shown to be an effective treatment for type 2 diabetes, and it is used to treat dyslipidemia and metabolic disorders. Saroglitazar has also been shown to have anti-inflammatory effects. Saroglitazar binds to PPAR receptors in the cell membrane, which leads to increased expression of lipoprotein lipase, a key enzyme in lipid metabolism. This effect results in an increase in the uptake of glucose from the blood into cells and improved insulin sensitivity. Saroglitazar has also been shown to activate Toll-like receptor 4 (TLR4), leading to increased expression of interleukin-10 (IL-10) and decreased production of tumor necrosis factor alpha (TNFα). This may be associated with its ability to inhibit HIV replication by downregulating viral transcriptional regulation.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
444.6 g/mol
Formula:
C25H24H5NO4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-VUA39909 Saroglitazar

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".